BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 38517344)

  • 21. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
    Dyson HJ; Wright PE
    J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.
    Wang F; Marshall CB; Ikura M
    Cell Mol Life Sci; 2013 Nov; 70(21):3989-4008. PubMed ID: 23307074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CBP and p300: HATs for different occasions.
    Kalkhoven E
    Biochem Pharmacol; 2004 Sep; 68(6):1145-55. PubMed ID: 15313412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.
    Culig Z
    J Cell Physiol; 2016 Feb; 231(2):270-4. PubMed ID: 26201947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic occupancy of the transcriptional co-activators p300 and CBP.
    Holmqvist PH; Mannervik M
    Transcription; 2013; 4(1):18-23. PubMed ID: 23131664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p300/CBP/p53 interaction and regulation of the p53 response.
    Grossman SR
    Eur J Biochem; 2001 May; 268(10):2773-8. PubMed ID: 11358491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.
    Wei J; Yang Y; Lu M; Lei Y; Xu L; Jiang Z; Xu X; Guo X; Zhang X; Sun H; You Q
    Mini Rev Med Chem; 2018; 18(4):296-309. PubMed ID: 27484627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjunction dysfunction: CBP/p300 in human disease.
    Giles RH; Peters DJ; Breuning MH
    Trends Genet; 1998 May; 14(5):178-83. PubMed ID: 9613201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CBP/p300 Degrader: A Promising Therapeutic Strategy for Treatment of Prostate Cancer and Beyond.
    Hu J; Xu Y
    J Med Chem; 2024 Apr; 67(7):5272-5274. PubMed ID: 38517344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
    Bordonaro M; Lazarova DL
    World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and function of androgen receptor coactivators in prostate cancer.
    Culig Z; Comuzzi B; Steiner H; Bartsch G; Hobisch A
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):265-71. PubMed ID: 15663989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease.
    Janknecht R
    Histol Histopathol; 2002 Apr; 17(2):657-68. PubMed ID: 11962765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulating the masters: chemical tools to dissect CBP and p300 function.
    Breen ME; Mapp AK
    Curr Opin Chem Biol; 2018 Aug; 45():195-203. PubMed ID: 30025258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.